tiprankstipranks
Lumos Pharma (LUMO)
NASDAQ:LUMO
US Market

Lumos Pharma (LUMO) Technical Analysis

327 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Lumos Pharma’s (LUMO) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Lumos Pharma is a Buy.
Lumos Pharma’s (LUMO) 20-Day exponential moving average is 2.82, while Lumos Pharma’s (LUMO) share price is $2.65, making it a Sell.
Lumos Pharma’s (LUMO) 50-Day exponential moving average is 2.91, while Lumos Pharma’s (LUMO) share price is $2.65, making it a Sell.

Lumos Pharma (LUMO) Pivot Points

Apr 28, 2024, 05:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.65
2.69
2.72
2.76
2.79
2.83
2.86
Fibonacci
2.69
2.72
2.74
2.76
2.79
2.81
2.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lumos Pharma (LUMO) Moving Averages

Apr 28, 2024, 05:59 PM
Period
Simple
Exponential
MA5
2.75Sell
2.74Sell
MA10
2.79Sell
2.77Sell
MA20
2.81Sell
2.82Sell
MA50
2.93Sell
2.91Sell
MA100
2.97Sell
3.01Sell
MA200
3.17Sell
3.16Sell
Lumos Pharma’s (LUMO) 10-Day exponential moving average is 2.77, while Lumos Pharma’s (LUMO) share price is $2.65, making it a Sell.
Lumos Pharma’s (LUMO) 100-Day exponential moving average is 3.01, while Lumos Pharma’s (LUMO) share price is $2.65, making it a Sell.
Lumos Pharma’s (LUMO) stock price is $2.65 and Lumos Pharma’s (LUMO) 50-day simple moving average is 2.93, creating a Sell signal.
Lumos Pharma’s (LUMO) stock price is $2.65 and Lumos Pharma’s (LUMO) 100-day simple moving average is 2.97, creating a Sell signal.
Lumos Pharma’s (LUMO) stock price is $2.65 and Lumos Pharma’s (LUMO) 200-day simple moving average is 3.17, creating a Sell signal.

Lumos Pharma (LUMO) Technical Indicators

Apr 28, 2024, 05:59 PM
Name
Value
Implied Action
RSI (14)
36.88
Neutral
STOCH (9,6)
35.24
Neutral
STOCHRSI (14)
35.24
Neutral
MACD (12,26)
-0.06
Buy
ADX (14)
25.60
Neutral
Williams %R
-85.71
Buy
CCI (14)
-95.28
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
41.38
Neutral
ROC
0.38
Buy
Lumos Pharma’s (LUMO) Relative Strength Index (RSI) is 36.88, creating a Neutral signal.
Lumos Pharma’s (LUMO) Trend Strength Indicator (ADX) is 25.60, creating a Neutral signal.
Lumos Pharma’s (LUMO) Commodity Channel Index (CCI) is -95.28, creating a Neutral signal.
Lumos Pharma’s (LUMO) Price Rate of Change (ROC) is 0.38, creating a Buy signal.

FAQ

Is LUMO a Buy, Hold, or Sell?
Based on LUMO’s technical indicators, LUMO is a Sell.
    What is LUMO’s RSI (14)?
    LUMO’s RSI (14) is 36.88, which suggests LUMO is a Neutral.
      What is LUMO’s MACD?
      LUMO’s MACD is -0.06, which suggests LUMO is a Buy.
        What is LUMO’s 5-day moving average?
        LUMO’s 5-day moving average is 2.75, which suggests LUMO is a Sell.
          What is LUMO’s 20-day moving average?
          LUMO 20-day moving average is 2.81, which suggests LUMO is a Sell.
            What is LUMO’s 50-day moving average?
            LUMO’s 50-day moving average is 2.93, which suggests LUMO is a Sell.
              What is LUMO’s 200-day moving average?
              LUMO’s 200-day moving average is 3.17, which suggests LUMO is a Sell.
                What is LUMO’s Williams % R (14)?
                LUMO’s Williams % R (14) is -85.71, which suggests LUMO is a Buy.
                  What is LUMO’s CCI (14)?
                  LUMO’s CCI (14) is -95.28, which suggests LUMO is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis